HCA Healthcare Equity Method Investments decreased by 3.2% to $633.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.4%, from $662.00M to $633.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 8.4% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $382.00M | $412.00M | $448.00M | $441.00M | $435.00M | $444.00M | $823.00M | $786.00M | $731.00M | $739.00M | $756.00M | $736.00M | $702.00M | $705.00M | $662.00M | $657.00M | $654.00M | $654.00M | $633.00M |
| QoQ Change | — | +7.9% | +8.7% | -1.6% | -1.4% | +2.1% | +85.4% | -4.5% | -7.0% | +1.1% | +2.3% | -2.6% | -4.6% | +0.4% | -6.1% | -0.8% | -0.5% | +0.0% | -3.2% |
| YoY Change | — | — | — | — | +13.9% | +7.8% | +83.7% | +78.2% | +68.0% | +66.4% | -8.1% | -6.4% | -4.0% | -4.6% | -12.4% | -10.7% | -6.8% | -7.2% | -4.4% |